SCHEMBL3661059

SCHEMBL3661059

CC(O)Cc1cc(C(=O)O)cc(-c2ccc(Cl)cn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 1/20 0.40
GABRA5 P31644 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
CTRC Q99895 2/20 0.39
GRIA2 P42262 1/20 0.38
LDHA P00338 4/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
LDHB P07195 1/20 0.37
MAPT P10636 1/20 0.37
P2RX7 Q99572 1/20 0.36
CYP2C9 P11712 1/20 0.36
P2RX3 P56373 1/20 0.36
P4HA1 P13674 1/20 0.36
P4HTM Q9NXG6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3662211 0.86 P2RX3 (0.42) NPC1RAB9ASMN1; SMN2TP53LDHA
SCHEMBL3072242 0.76 LDHA (0.42) NPC1RAB9ASMN1; SMN2TP53GABRA5
SCHEMBL2273188 0.75 LDHA (0.44) NPC1RAB9ASMN1; SMN2GABRA5CTRC
SCHEMBL3068918 0.73 CYP2C9 (0.52) NPC1RAB9ASMN1; SMN2TP53GABRA5
SCHEMBL3657654 0.73 NPC1 (0.36) NPC1RAB9ASMN1; SMN2TP53GABRA5
SCHEMBL2760957 0.72 NPC1 (0.41) NPC1RAB9ASMN1; SMN2TP53LDHA
SCHEMBL22395356 0.72 RXRA (0.47) CTRCLDHACYP2C9P2RX3
SCHEMBL2949623 0.71 LDHA (0.61) NPC1RAB9ASMN1; SMN2TP53CTRC
SCHEMBL357773 0.70 ALDH1A1 (0.39) SMN1; SMN2TP53GABRA5GRIA2LDHA
SCHEMBL17185972 0.68 LMNA (0.37) NPC1RAB9ASMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215049-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN Merck Sharp & Dohme Corp. (US) 2010-08-11 EP disclosed
WO-2009058298-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN MERCK & CO., INC. (US) 2009-05-07 WO disclosed